SHENZHEN FEI SIFANG INFORMATION TECHNOLOGY CO., LTD. – Trademark Portfolio

Entity Type: 16

SHENZHEN FEI SIFANG INFORMATION TECHNOLOGY CO., LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 25 (Clothing) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include HISOSO. The owner is based in SHENZHEN.

ROOM 501, NO.1, SOUTH NO.3 LANE, HEKAN ROAD, WUHE COMMUNITY

BANTIAN STREET, LONGGANG DISTRICT,

SHENZHEN 518129 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

HISOSO
HISOSO
Registered 2025

Trademark Classifications

SHENZHEN FEI SIFANG INFORMATION TECHNOLOGY CO., LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

25
Clothing (1 filing)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does SHENZHEN FEI SIFANG INFORMATION TECHNOLOGY CO., LTD. have?

SHENZHEN FEI SIFANG INFORMATION TECHNOLOGY CO., LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does SHENZHEN FEI SIFANG INFORMATION TECHNOLOGY CO., LTD. file in?

SHENZHEN FEI SIFANG INFORMATION TECHNOLOGY CO., LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 25 (Clothing). Class 25 covers clothing, footwear, headgear.

What are SHENZHEN FEI SIFANG INFORMATION TECHNOLOGY CO., LTD.'s most well-known trademarks?

SHENZHEN FEI SIFANG INFORMATION TECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as HISOSO. These are among 1 currently registered trademark in the portfolio.

What is SHENZHEN FEI SIFANG INFORMATION TECHNOLOGY CO., LTD.'s trademark registration success rate?

SHENZHEN FEI SIFANG INFORMATION TECHNOLOGY CO., LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.